Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4114 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Pfizer wins patent struggle over Norvasc

The patent covers amlodipine besylate, the active ingredient in Norvasc needed for making low cost alternatives. Since the ruling in favor of Pfizer makes clear the patent is

Peregrine accelerates Tarvacin development

As a result of rapid enrollment in the phase I hepatitis C virus (HCV) infection study, Peregrine is now targeting completion of patient dosing in February, several months

Aphios forms subsidiary to develop natural flu drugs

Amyxa will screen a unique library of diverse marine microorganisms, isolated from normal to extremeophilic environments in US territorial waters, and medicinal plants to discover novel anti-influenza drugs.

Novartis partners Ablynx in nanobody research

Ablynx originally pioneered nanobody discovery. Now both companies will collaborate to discover and develop novel nanobody-based therapeutics against disease targets that are difficult to address with conventional antibodies

Large scale analysis shows Lipitor is safe

The analysis, which included Lipitor clinical trials that were initiated and completed between 1992 and 2004, tracked the incidence of non-serious and serious muscle, liver and kidney adverse

Avax initiates lung cancer vaccine trial

The vaccine is composed of tumor cells obtained from each patient’s tumor that are modified with dinitrophenyl. Endpoints of the study include safety and a measure of each